Company: PTPI
Filing Date: 2025-02-19
Form Type: 424B4
Source: 0001410578-25-000164
Chunk: 14

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-19
Form: 424B4
Chunk 14
---
 under the Promissory Note. |

| ● | Any difficulties or delays in product engineering, regulatory compliance, sales or marketing could affect Petros’ future results. |

| ● | Petros’ technology may be viewed as relatively new or untested, which could result in regulatory delays or disruptions in the pathway to commercialization. |

| ● | If Petros fail to successfully initiate broad commercialization of, market and sell its platform cost-effectively, its sales, business, financial condition and results of operations will be negatively affected. |

| ● | Cyberattacks and other data security breaches could compromise its proprietary and confidential information, which could harm its business and reputation or cause it to incur increased expenses to address any such breaches. |

| ● | Because Petros is a small company with limited resources, it may be unable to attract qualified personnel. |

| ● | Rx-to-OTC switches are part of Petros’ future growth, and may be affected by regulatory developments governing Rx-to-OTC switches. |

| ● | Petros may not receive the necessary authorizations to market its platform or any future new products, and any failure to timely do so may adversely affect its ability to grow our business. |

| ● | Ongoing changes in healthcare regulation could negatively affect Petros’ revenues, business and financial condition. |

| ● | We may not have sufficient cash to develop our platform, even after the proceeds raised in this offering. |

| ● | Petros may be subject to certain federal, state, and foreign fraud and abuse laws, health information privacy and security laws, and transparency laws, which, if violated, could subject it to substantial penalties. Additionally, any challenge to or investigation into its practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm its business. |

| ● | Since Petros’ platform will utilize cloud-based information systems and the exchange of information between patents and doctors, Petros will be subject to numerous U.S. federal and state laws and regulations related to the privacy and security of personally identifiable information, including health information. |

| ● | Petros’ business will expose it to potential liability for the quality and safety of its products and services, how it advertises and markets those products and services and how and to whom it sells them, and Petros may incur substantial expenses or be found liable for substantial damages or penalties if it is subject to claims or litigation. |

| ● | The Vivus Event of Default constitutes a Triggering Event (as defined in the